AMRX Competitors & Alternatives
Compare Amneal Pharmaceuticals, Inc. Class A Common Stock with similar stocks in the same industry
Drug Manufacturers - Specialty & Generic
AMRX
Main Stock$17.18
Tradestie Score
53
Market Cap
$3.26B
P/E Ratio
46.0
Revenue Growth
0.0%
Analyst Upside
+0.4%
Top Competitors
45 stocks in Drug Manufacturers - Specialty & Generic| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RGC
Regencell Bioscience Holdings Limited Ordinary Shares
|
$5.05
|
$7.83B | - | 47 | Compare |
|
ALKS
Alkermes Inc. plc
|
$51.87
|
$5.06B | 57.7 | 61 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$129.89
|
$3.98B | - | 67 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$105.39
|
$3.51B | 25.2 | 51 | Compare |
|
PBH
Prestige Consumer Healthcare Inc.
|
$48.83
|
$3.12B | 12.5 | 58 | Compare |
|
PRGO
PERRIGO COMPANY PLC
|
$10.17
|
$3.10B | - | 58 | Compare |
|
INDV
Indivior PLC Ordinary Shares
|
$40.21
|
$2.93B | 20.8 | 61 | Compare |
|
KNSA
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
|
$60.94
|
$2.86B | 69.7 | 65 | Compare |
|
HCM
HUTCHMED (China) Limited American Depositary Shares
|
$11.14
|
$2.74B | 4.2 | 52 | Compare |
|
SUPN
Supernus Pharmaceuticals, Inc.
|
$47.35
|
$2.69B | - | 60 | Compare |
More AMRX Analysis
Data updated: Jul 14, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)
45 stocks in this industry